AI Bias in Healthcare: How Algorithms Can Discriminate

By Newsroom, Science & Technology Desk — Published August 2, 2026

Table of Contents

• How Bias Enters Healthcare Algorithms
• Real-World Consequences for Patients
• The Role of Regulation and Oversight
• Pathways Toward Fairer Systems
• Frequently Asked Questions

When a hospital emergency room uses an algorithm to predict which patients need the most urgent care, lives hang in the balance. The same is true when software helps decide who gets approved for kidney transplants, or when an AI system screens mammograms for early signs of cancer. These tools promise precision and efficiency, yet a troubling pattern has emerged: bias in healthcare algorithms can replicate and even amplify the very inequities medicine has long struggled to overcome. Understanding how this happens—and what can be done about it—matters to anyone who will one day be a patient.

Artificial intelligence and machine learning systems learn from data. Feed them thousands of medical records, and they’ll spot patterns invisible to the human eye. But those records carry the fingerprints of an imperfect healthcare system, one shaped by centuries of unequal access, mistrust, and assumptions about which bodies are “normal.” The result is technology innovation trends that can bake discrimination directly into clinical decision-making, often in ways invisible to the doctors and nurses who rely on them.

How Bias Enters Healthcare Algorithms

The mechanism is deceptively simple. An algorithm trained on historical patient data will reflect whatever biases existed in that data. If Black patients historically received less aggressive pain management, the AI learns that pattern. If women’s cardiac symptoms were dismissed more often than men’s, that becomes part of the model’s understanding of heart disease. The algorithm doesn’t know it’s learning prejudice—it just sees numbers.

One well-documented example involved a widely used algorithm designed to identify patients who would benefit from extra medical care. The system used healthcare spending as a proxy for medical need. Sounds reasonable, except that Black patients in the dataset had systematically received less care—and therefore generated lower costs—than equally sick white patients. The algorithm interpreted this spending gap as evidence that Black patients were healthier. Scientific research findings published in peer-reviewed research journals revealed that this single tool affected millions of patients, with Black individuals far less likely to be flagged for programs that could have improved their outcomes.

Training data represents just one entry point for bias. The choice of what to measure matters enormously. Should an algorithm prioritize lab values, symptoms, or past diagnoses? Each choice privileges certain kinds of knowledge. Laboratory studies might seem objective, but which tests get ordered in the first place often depends on a doctor’s assumptions about a patient’s risk factors—assumptions that can be shaped by race, gender, age, or socioeconomic status.

Common Sources of Algorithmic Bias

• Historical inequities in care: Datasets reflect past patterns of undertreatment, misdiagnosis, or delayed intervention for marginalized groups
• Proxy variables: Using healthcare costs, insurance status, or ZIP codes as stand-ins for medical need imports socioeconomic disparities into clinical predictions
• Missing populations: If certain demographic groups are underrepresented in training data, algorithms perform poorly when encountering those patients
• Feature selection: Choosing which patient characteristics to include—or exclude—can inadvertently encode assumptions about who deserves what kind of care
• Validation gaps: Testing an algorithm on the same population used to build it masks problems that emerge when the tool is deployed more broadly

Real-World Consequences for Patients

Abstract discussions of bias become concrete when you’re the patient denied a referral or treatment. Diagnostic algorithms trained primarily on data from lighter-skinned individuals have shown reduced accuracy in detecting skin conditions on darker skin. Pulse oximeters, devices that measure blood oxygen levels, have been found to overestimate oxygen saturation in Black patients—a critical error during respiratory illnesses. These aren’t minor glitches. They’re failures that can delay diagnosis, result in inappropriate treatment, or lead clinicians to underestimate disease severity.

The digital transformation of healthcare amplifies these risks. As hospitals and clinics adopt AI tools for everything from scheduling to surgery planning, a biased algorithm doesn’t just affect one patient—it shapes thousands of clinical encounters. The scale is what makes this urgent. A human doctor’s implicit bias might affect their own patients. A flawed algorithm deployed across a health system affects everyone who walks through the door.

Consider organ transplant allocation. Kidney function is often estimated using equations that include race as a variable, based on outdated assumptions about muscle mass and metabolism. For years, this meant Black patients appeared to have better kidney function than they actually did, making them wait longer for transplants. When the medical community began removing race from these calculations, the implications were stark: thousands of patients had been disadvantaged by a formula presented as neutral science.

The Role of Regulation and Oversight

Medical device approval processes in many countries were designed for physical tools—scalpels, monitors, implants. Software is different. It can be updated remotely, trained on new data, and deployed in contexts far removed from where it was tested. Regulatory frameworks are playing catch-up.

Some health systems now require algorithmic impact assessments before deploying AI tools, examining how the system performs across different demographic groups. This represents progress, but challenges remain. Who decides what counts as acceptable disparity? A tool that’s 95 percent accurate overall might be only 80 percent accurate for a specific subgroup—is that a reason to reject it, or to use it with extra caution for certain patients? There’s no universal answer, and the tech industry developments in this space are moving faster than consensus can form.

The question of transparency cuts deep. Many healthcare algorithms are proprietary, their inner workings protected as trade secrets. Clinicians may not know exactly how a recommendation was generated, making it difficult to spot errors or advocate for patients who don’t fit the model’s assumptions. Calls for “explainable AI” in healthcare stem from this tension between innovation and accountability.

Pathways Toward Fairer Systems

Fixing biased algorithms isn’t as simple as removing demographic variables. Strip out race or gender, and the algorithm might just latch onto proxies—neighborhood, insurance type, even first names can correlate with protected characteristics. The solution requires rethinking the entire pipeline, from data collection to deployment.

Diverse development teams help. When the people building healthcare AI come from varied backgrounds, they’re more likely to ask whose experiences are missing from the data and which assumptions need questioning. But diversity alone won’t solve the problem if the underlying data remains skewed. Some researchers advocate for collecting better data that captures the full range of human variation, while others warn that more data can mean more opportunities to encode bias.

Emerging technologies in this field include fairness-aware machine learning techniques that explicitly optimize for equity across groups, not just overall accuracy. These methods force algorithms to perform comparably well for different populations, though they sometimes involve trade-offs. An algorithm constrained to be equally accurate for everyone might be slightly less accurate overall than one allowed to optimize for the majority group. Whether that trade-off is worthwhile depends on your values and priorities—a question that can’t be answered by mathematics alone.

Public health and epidemiology perspectives emphasize the need for ongoing monitoring. An algorithm that seems fair at launch can drift as patient populations change or as the healthcare system evolves. Continuous evaluation, broken down by demographic categories, helps catch problems before they become entrenched.

Frequently Asked Questions

Can’t we just remove race and gender from healthcare algorithms to eliminate bias?

Removing demographic variables is a start, but it’s not sufficient. Algorithms can still learn biased patterns from other data points that correlate with race or gender, such as ZIP codes, insurance types, or even patterns in medical history that reflect past discrimination. True fairness requires examining the entire system—what data is collected, how it’s labeled, what outcomes are being predicted, and whether those outcomes themselves are equitable measures of what patients need.

How can patients tell if they’re being affected by algorithmic bias?

This is genuinely difficult. Most patients never know when an algorithm influenced their care, and even clinicians may not have full visibility into how AI tools reach their conclusions. Patients can ask their doctors whether computer systems are being used to guide diagnosis or treatment decisions, and whether those tools have been tested across diverse populations. Advocating for yourself—asking why a particular recommendation was made, seeking second opinions, and questioning decisions that seem inconsistent with your symptoms—remains important regardless of whether AI is involved.

Are newer AI systems less biased than older ones?

Not automatically. While awareness of algorithmic bias has grown and some developers now test for fairness more rigorously, newer systems can still inherit problems from their training data or introduce new issues. The rapid pace of healthcare AI development sometimes outstrips our ability to evaluate these tools thoroughly. Age of the technology matters less than the rigor of its development process, the diversity of its testing, and the transparency of its deployment.

Who is responsible when a biased algorithm harms a patient?

Accountability remains murky. Is it the software developer, the hospital that purchased the tool, the clinician who relied on its output, or the regulatory body that approved it? Legal and ethical frameworks are still evolving. Many argue that healthcare institutions bear responsibility for auditing the tools they deploy and ensuring they don’t worsen existing disparities. But as algorithms become more complex and their decision-making less transparent, assigning responsibility becomes harder—one reason why calls for stronger oversight and clearer standards continue to grow.

The promise of AI in healthcare is real. These tools can process vast amounts of information, spot subtle patterns, and help overwhelmed clinicians make better decisions. But promise and peril often travel together. As healthcare systems embrace algorithmic decision-making, the challenge is ensuring these powerful tools serve all patients equitably. That requires vigilance, transparency, and a willingness to ask hard questions about whose knowledge counts, whose bodies are considered normal, and whose suffering gets taken seriously. Technology can amplify the best of medicine—or the worst. The choice belongs to all of us.